Pharmacovigilance is vital for patient safety and market success in the Middle East and GCC, ensuring compliance with SFDA, EDA, MOHAP. Robust systems, local expertise, and proactive risk management sustain market authorization and trust.
Middle East and GCC pharma regulations are rapidly evolving with digital submissions, stricter pharmacovigilance, biotech scrutiny, and tougher device registration, requiring strategic compliance and local expertise.
7 Emerging Trends in Middle Eastern and GCC Pharma Regulations to Watch Now Read More »
PharmaOasis Germans EG offers expert pharmacovigilance support in the Middle East and GCC, ensuring compliance with SFDA and EDA regulations through local expertise, robust risk management, and digital intelligence.
